Recruiting
Phase 2

Anifrolumab for Hidradenitis Suppurativa

Sponsor:

University of North Carolina, Chapel Hill

Code:

NCT06374212

Conditions

Hidradenitis Suppurativa

Acne Inversa

Hidradenitis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Anifrolumab

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information